Compare HOPE & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HOPE | AMPH |
|---|---|---|
| Founded | 1986 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1996 | 2014 |
| Metric | HOPE | AMPH |
|---|---|---|
| Price | $12.11 | $28.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $13.75 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 998.3K | 297.9K |
| Earning Date | 01-27-2026 | 02-27-2026 |
| Dividend Yield | ★ 4.61% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.49 | ★ 2.27 |
| Revenue | $456,353,000.00 | ★ $723,305,000.00 |
| Revenue This Year | $37.08 | $1.37 |
| Revenue Next Year | $9.82 | $4.84 |
| P/E Ratio | $24.99 | ★ $12.56 |
| Revenue Growth | ★ 1.73 | N/A |
| 52 Week Low | $8.83 | $20.39 |
| 52 Week High | $12.79 | $32.69 |
| Indicator | HOPE | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 54.22 | 57.21 |
| Support Level | $11.76 | $27.24 |
| Resistance Level | $12.50 | $29.09 |
| Average True Range (ATR) | 0.35 | 0.89 |
| MACD | -0.04 | 0.08 |
| Stochastic Oscillator | 38.10 | 73.77 |
Hope Bancorp Inc is a bank holding company engaged in providing financial services. It offers core business banking products for small and medium-sized businesses and individuals. Services offered by the bank include online banking, mobile banking, mortgage loans, credit cards, investment and wealth management services and other banking services.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.